Insomnia is common among patients on maintenance haemodialysis and may be exacerbated by the challenges of the COVID pandemic. However, data on the efficacy of insomnia interventions in this population are limited. Efforts are needed to address this important problem and increase access to insomnia interventions for patients on haemodialysis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Occurrence of benzodiazepines and nonbenzodiazepines usage among newly-onset of peritoneal dialysis versus hemodialysis patients
BMC Nephrology Open Access 27 November 2025
-
The relationship between fatigue, pruritus, and thirst distress with quality of life among patients receiving hemodialysis: a mediator model to test concept of treatment adherence
Scientific Reports Open Access 01 May 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Roumelioti, M. E. Argyropoulos, C. P. & Unruh, M. L. in Psychosocial Aspects of Chronic Kidney Disease (eds Cukor, D., Cohen, S. & Kimmel, P.) 183–212 (Academic Press, 2020).
Anand, S. et al. Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: the comprehensive dialysis study. Hemo. Int. 17, 50–58 (2013).
Morin, C. M. et al. Insomnia disorder. Nat. Rev. Dis. Primers 1, 1–18 (2015).
Flythe, J. E. et al. Symptom prioritization among adults receiving in-center hemodialysis: a mixed methods study. CJASN 13, 735–745 (2018).
Perl, J., Unruh, M. L. & Chan, C. T. Sleep disorders in end-stage renal disease: ‘markers of inadequate dialysis?’. Kid. Int. 70, 1687–1693 (2006).
Maung, S. et al. Sleep disturbance and depressive affect in patients treated with haemodialysis. J. Ren. Care 43, 60–66 (2017).
Lee, J. et al. Psychosocial impact of COVID-19 pandemic on patients with end-stage kidney disease on hemodialysis. Kidney360 1, 1390–1397 (2020).
Brasure, M. et al. Psychological and behavioral interventions for managing insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann. Intern. Med. 165, 113–124 (2016).
Winkelmayer, W. C., Mehta, J. & Wang, P. S. Benzodiazepine use and mortality of incident dialysis patients in the United States. Kid. Int. 72, 1388–1393 (2007).
Unruh, M. et al. Sleep-HD trial: short and long-term effectiveness of existing insomnia therapies for patients undergoing hemodialysis. BMC Nephrol. 21, 1–12 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Cukor, D., Unruh, M., McCurry, S.M. et al. The challenge of insomnia for patients on haemodialysis. Nat Rev Nephrol 17, 147–148 (2021). https://doi.org/10.1038/s41581-021-00396-5
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41581-021-00396-5
This article is cited by
-
Occurrence of benzodiazepines and nonbenzodiazepines usage among newly-onset of peritoneal dialysis versus hemodialysis patients
BMC Nephrology (2025)
-
The relationship between fatigue, pruritus, and thirst distress with quality of life among patients receiving hemodialysis: a mediator model to test concept of treatment adherence
Scientific Reports (2024)
-
Changes in symptom burden in the first 6 months after dialysis commencement: a prospective longitudinal observational cohort study
Journal of Nephrology (2023)